Nonalcoholic Fatty Pancreas Disease

Nihar Shah; Jason P. Rocha; Neal Bhutiani; Omer Endashaw

doi:10.1002/ncp.10397

Nonalcoholic Fatty Pancreas Disease

Nihar Shah, Jason P. Rocha, Neal Bhutiani, Omer Endashaw

Division of Gastroenterology

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

Abstract

Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.

Original language	English (US)
Pages (from-to)	S49-S56
Journal	Nutrition in Clinical Practice
Volume	34
Issue number	S1
DOIs	https://doi.org/10.1002/ncp.10397
State	Published - Oct 1 2019

Keywords

fatty liver
fatty pancreas
metabolic syndrome
obesity
pancreas
pancreatic disease

ASJC Scopus subject areas

Medicine (miscellaneous)
Nutrition and Dietetics

Access to Document

10.1002/ncp.10397

Cite this

@article{491db062196a4685bb4499c3fbcd31ed,

title = "Nonalcoholic Fatty Pancreas Disease",

abstract = "Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.",

keywords = "fatty liver, fatty pancreas, metabolic syndrome, obesity, pancreas, pancreatic disease",

author = "Nihar Shah and Rocha, {Jason P.} and Neal Bhutiani and Omer Endashaw",

note = "Publisher Copyright: {\textcopyright} 2019 American Society for Parenteral and Enteral Nutrition",

year = "2019",

month = oct,

day = "1",

doi = "10.1002/ncp.10397",

language = "English (US)",

volume = "34",

pages = "S49--S56",

journal = "Nutrition in Clinical Practice",

issn = "0884-5336",

publisher = "John Wiley & Sons Inc.",

number = "S1",

}

TY - JOUR

T1 - Nonalcoholic Fatty Pancreas Disease

AU - Shah, Nihar

AU - Rocha, Jason P.

AU - Bhutiani, Neal

AU - Endashaw, Omer

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.

AB - Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.

KW - fatty liver

KW - fatty pancreas

KW - metabolic syndrome

KW - obesity

KW - pancreas

KW - pancreatic disease

UR - http://www.scopus.com/inward/record.url?scp=85072383974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072383974&partnerID=8YFLogxK

U2 - 10.1002/ncp.10397

DO - 10.1002/ncp.10397

M3 - Review article

C2 - 31535735

AN - SCOPUS:85072383974

SN - 0884-5336

VL - 34

SP - S49-S56

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

IS - S1

ER -

Nonalcoholic Fatty Pancreas Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this